COVID testing demand drives growth for Abbott's diagnostics arm

Abbott's global COVID testing-related sales totaled $3.3 billion during the quarter, led by continued demand for rapid testing products.

Related Keywords

Michigan ,United States ,Robert Ford ,Abbott Laboratories ,Medical Devices ,Established Pharmaceuticals ,